Clinical Trial Update: Treatment of Hyperhidrosis With Oxybutynin [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for oxybutynin in the treatment of hyperhidrosis has completed. The sponsor is University Hospital, Brest.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• oxybutynin (oxybutynin)

Snippet

Sponsor: University Hospital, Brest | Conditions: Hyperhidrosis | Phase 3 | Status: COMPLETED